The evolution of azole resistance through a reduced spore dormancy pathway associated with loss of SUMOylation function in <i>Fusarium graminearum</i>. [PDF]
Wog K +3 more
europepmc +1 more source
Breakthrough Tracheobronchial Aspergillosis Caused by <i>Aspergillus calidoustus</i> and <i>Aspergillus niger</i> in a Lung Transplant Recipient Despite Combined Antifungal Prophylaxis. [PDF]
Calvache Benavides CE +4 more
europepmc +1 more source
Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study. [PDF]
Maertens J +13 more
europepmc +1 more source
Prochelators modulate azole activity against <i>Candida albicans</i> in a metal-dependent manner. [PDF]
Merriman MA +6 more
europepmc +1 more source
Regulation of ABC Transporters and Ergosterol Biosynthesis by the Transcription Factor FvADS-1 Controls Azole Resistance and Virulence in <i>Fusarium verticillioides</i>. [PDF]
Yin Y +5 more
europepmc +1 more source
The Effect of <i>N</i>-Alkyl Azole Difluorination on Molecular Properties Relevant for Compound Optimization: A Comparative Study. [PDF]
Herrick RM +5 more
europepmc +1 more source
Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus. [PDF]
Pinder C +5 more
europepmc +1 more source
Tisdale-score-based risk stratification of QTc prolongations in hospitalized patients receiving azole antifungal therapy-a retrospective study. [PDF]
Steinbrech J +4 more
europepmc +1 more source
A breakthrough invasive <i>Aspergillus granulosus</i> infection following azole antifungal therapy in a patient with primary myelofibrosis: case report. [PDF]
Jaroensawang W +3 more
europepmc +1 more source
Novel cyp51A mutation profile in Aspergillus fumigatus from a patient with systemic lupus erythematosus and limited systemic sclerosis: first clinical case of acquired azole-resistance in Colombia. [PDF]
Morales-Pertuz C +6 more
europepmc +1 more source

